{"id":"W4400650260","doi":"10.1001/jamainternmed.2024.2559","title":"Access to GLP-1 Weight Loss Drugs in the US, Canada, Switzerland, and Germany","year":2024,"lang":"en","type":"article","venue":"JAMA Internal Medicine","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"","keywords":"Medicine; Weight loss; Glucagon-like peptide-1; Exenatide; Glucagon-like peptide 1 receptor; Internal medicine; Obesity; Endocrinology; Diabetes mellitus; Receptor; Agonist; Type 2 diabetes","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000385956,0.0001638903,0.0002604788,0.0001922355,0.00002857545,0.00007402954,0.0002240221,0.00003895823,0.0002889179],"category_scores_gemma":[0.00009224568,0.00008574092,0.00002857448,0.0002536177,0.0000536488,0.000114782,0.0001091386,0.0002956938,0.00002719713],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001651275,"about_ca_system_score_gemma":0.00009611343,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.1852645,"about_ca_topic_score_gemma":0.1168002,"domain_scores_codex":[0.9987303,0.0000346499,0.0002493845,0.0002603188,0.0004755173,0.000249841],"domain_scores_gemma":[0.9993588,0.0002133115,0.0000262308,0.0002145319,0.00003163224,0.0001555288],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0003573335,0.0001159656,0.2158862,0.0006920527,0.0004345293,0.005161995,0.006002044,0.00000162871,0.0001664002,0.001975064,0.6646431,0.1045637],"study_design_scores_gemma":[0.001718736,0.0003726784,0.3541119,0.001910434,0.0001765773,0.00008523511,0.0002969753,0.0001467013,0.0001397808,0.0001214608,0.6408155,0.0001040639],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.8111263,0.002143596,0.00003107856,0.159967,0.0007790746,0.0004514195,0.000006190007,0.00002729282,0.02546809],"genre_scores_gemma":[0.9715213,0.0003045677,0.00001701001,0.02092263,0.0008055622,0.00005563803,0.00001465607,0.00001614534,0.006342501],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.160395,"threshold_uncertainty_score":0.899316,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.009186637104439958,"score_gpt":0.2770989490329122,"score_spread":0.2679123119284723,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}